已收盤 02-06 16:00:00 美东时间
-0.010
-0.20%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据American Vanguard (AVD)业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **成本控制表现突出:** - 运营成本季度同比下降11%(减少500万美元),年初至今下降14%(减少1800万美元) - 转型相关支出在九个月期间减少约1100万美元 - 销售费用、一般管理费用和研发费用均实现削减,主要得益于全球组织架构精简和SIMPASS项目支出取消 **营运资金管理改善:** - 库存较去年同期减少约4700万美元 - 净贸易营运资金较去年同期减少2400万美元,主要归功于改进的SIOP流程 - 净债务较去年同期减少
2025-11-11 12:02
American Vanguard (NYSE:AVD) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 11.11 percent decrease over losses of $(0.09) per share from the
2025-11-10 21:25
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Avada Group Limited ( ($AU:AVD) ) has issued an update. Avada Group Limited has...
2025-09-22 13:57
American Vanguard shares are trading higher after the company reported better-t...
2025-08-01 01:47
American Vanguard (NYSE:AVD) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.11) by 72.73 percent. This is a 92.86 percent increase over losses of $(0.42) per share from
2025-08-01 01:04
The latest announcement is out from American Vanguard ( ($AVD) ). At the 2025 A...
2025-07-08 04:50
An announcement from Avada Group Limited ( ($AU:AVD) ) is now available. Avada ...
2025-06-30 10:07
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Metsera(MTSR)"买入"评级,目标价从56美元升至62美元</p> <p>• 摩根大通:维持Avidity Biosciences(RNA)"超配"评级,目标价从57美元升至59美元</
2025-06-11 09:43